seed
Stage
1
Investors
About
Bitrobius develops Gentrafix™, a gene therapy technology that delivers self-replicating DNA plasmids to spread corrected genes for treating genetic diseases including mitochondrial disorders.
Explore Bitrobius's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.